Inventor · Lake Forest Park, WA, US

Daniel S. Allison

33Patents
5h-index
36Co-inventors
69Inventor score

Filing activity: May 1, 1997 → Jun 27, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US5888809A Hamster EF-1.alpha. transcriptional regulatory DNA Chemistry; Metallurgy 51 Expired
US9102724B2 Anti-FZD10 monoclonal antibodies and methods for their use Chemistry; Metallurgy 15 Active
US9518082B2 Antibody purification and purity monitoring Chemistry; Metallurgy 13 Active
US10533045B2 Antibody purification and purity monitoring Chemistry; Metallurgy 9 Active
US10202435B2 Anti-PACAP antibodies and uses thereof Emerging Cross-Sectional Technologies 6 Active
US9677070B2 Composition and method for diversification of target sequences Chemistry; Metallurgy 5 Active
US8609818B2 Generation of anti-FN14 monoclonal antibodies by ex-vivo accelerated antibody evolution Chemistry; Metallurgy 2 Active
US10954285B2 Humanized anti-PACAP antibodies Emerging Cross-Sectional Technologies 1 Active
US9688754B2 Anti-ACTH antibodies and use thereof Chemistry; Metallurgy 1 Active
US10047157B2 Humanized anti-ACTH antibodies and use thereof Chemistry; Metallurgy 1 Active
US11117960B2 Humanized anti-ACTH antibodies and use thereof Chemistry; Metallurgy 1 Active
US10259885B2 Anti-PCSK9 antibodies and use thereof Physics 1 Active
US11427631B2 Anti-ACTH antibodies and use thereof Chemistry; Metallurgy 1 Active
US10913783B2 Humanized anti-PACAP antibodies and uses thereof Emerging Cross-Sectional Technologies 1 Active
US10544214B2 Humanized anti-ACTH antibodies and use thereof Chemistry; Metallurgy 1 Active
US10550180B2 Anti-ACTH antibodies and use thereof Chemistry; Metallurgy 1 Active
US10968268B2 Humanized anti-PACAP antibodies Emerging Cross-Sectional Technologies 1 Active
US10975135B2 Humanized anti-PACAP antibodies Emerging Cross-Sectional Technologies 1 Active
US9346888B2 Generation of anti-FN14 monoclonal antibodies by ex-vivo accelerated antibody evolution Chemistry; Metallurgy 1 Active
US11254741B2 Anti-PACAP antibodies Emerging Cross-Sectional Technologies 0 Active
US12077581B2 Anti-PACAP antibodies and uses thereof Emerging Cross-Sectional Technologies 0 Active
US11352409B2 Anti-PACAP antibodies and uses thereof Emerging Cross-Sectional Technologies 0 Active
US10844116B2 Use of anti-pacap antibodies and antigen binding fragments thereof for treatment, prevention, or inhibition of photophobia Emerging Cross-Sectional Technologies 0 Active
US12428475B2 Humanized anti-ACTH antibodies and use thereof Chemistry; Metallurgy 0 Active
US12162936B2 Methods of treatment with anti-PACAP antibodies Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.